- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Ajooni Biotech's board has approved the financial results for the quarter ending June 30, 2025. The company reported revenue from operations of ₹31.27 Cr, a modest increase from ₹29.27 Cr in the same quarter last year. However, net profit for the period saw a notable decline, dropping to ₹0.78 Cr from ₹1.54 Cr previously. This substantial drop in profitability is a key takeaway for investors, despite slight revenue growth. Investors should monitor future reports for clarification on the profit margin compression.